Rockwell Medical, Inc. RMTI

Minot Light Capital Partners, an investment management company, released its Q2 2026 investment letter. A copy of the letter can be downloaded here. In the quarter, the partnership generated gross and net returns of 26.2% and 20.3%, respectively, bringing year-to-date returns to 22.8% gross and 17.1% net. Since inception 21 months ago, gross and net […]

Rockwell Medical Inc (RMTI) expands gross margins to 18% and reiterates full-year guidance amid strategic West Coast growth.

Moby summary of Rockwell Medical, Inc.'s Q2 2026 earnings call

WIXOM, Mich., August 13, 2026--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive operating cash flow.

WIXOM, Mich., July 22, 2026--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the Company.

WIXOM, Mich., July 20, 2026--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

WIXOM, Mich., July 16, 2026--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.

The company’s board of directors approved a 1-for-10 reverse stock split, which will take effect on July 1, 2026

WIXOM, Mich., June 29, 2026--Rockwell Medical's Board of Directors has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock.

Moby summary of Rockwell Medical, Inc.'s Q1 2026 earnings call